Exact inference for adaptive group sequential designs

Statistics in Medicine

Volumn 32, Issue 23, 2013, Pages 3991-4005

  Gao, Ping ^a   Liu, Lingyun ^b   Mehta, Cyrus ^b,c  

^a MEDICINES COMPANY   (United States)

^b Cytel Corporation   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adaptive median unbiased estimates; Estimation in adaptive design; Exact adaptive confidence intervals; Group sequential estimation

Indexed keywords

ADAPTATION; ANALYTIC METHOD; ARTICLE; BIOTECHNOLOGY; BRAIN DEPTH STIMULATION; COMPUTER SIMULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; PARKINSON DISEASE; PROBABILITY; SAMPLE SIZE; SEQUENTIAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS; METHODOLOGY; QUALITY OF LIFE; STANDARDS; STATISTICAL ANALYSIS;

COMPUTER SIMULATION; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84884703868     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5847     Document Type: Article

References (17)

1. DIA-ADSWG Survey Subteam. Perception and use of adaptive designs in the industry and academia: persistent barriers and recommendations to overcome challenges. Unpublished Manuscript presented at the DIA Adaptive Designs in Clinical Trials Meeting on Nov 30, 2012, Washington DC, 2012.
2. Mehta CR, Pocock SJ. Adaptive increase in sample size when interim results are promising: a practical guide with examples. Statistics in Medicine 2011; 30(28):3267-3284.
3. Mehta CR. Sample size re-estimation for confirmatory clinical trials. In Chapter 4 of Designs for Clinical Trials, Harrington D (ed.). Springer: New York, 2012; 81-108.
4. Food and Drug Administration. Guidance for industry-adaptive design clinical trials for drugs and biologics, 2010.
5. Cui L, Hung MJ, Wang S-J. Modification of sample size in group sequential clinical trial. Biometrics 1999; 55:853-857.
6. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999; 55:1286-1290.
7. Müller HH, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantage of adaptive and of classical group sequential approaches. Biometrics 2001; 57:886-891.
8. Jennison C, Turnbull BW. Interim analyses: the repeated confidence interval approach (with discussion). Journal of the Royal Statistical Society B 1989; 51(3):305-61.
9. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman and Hall/CRC: London, 2000.
10. Mehta CR, Bauer P, Posch M, Brannath W. Repeated confidence intervals for adaptive group sequential trials. Statistics in Medicine 2007; 26(30):5422-5433.
11. Brannath W, Mehta C, Posch M. Exact confidence intervals following adaptive sequential tests. Biometrics 2009; 64:1-22.
12. Tsiatis AA, Rosner GL, Mehta C. Exact confidence intervals following a group sequential test. Biometrics 1984; 40:797-803.
13. Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society A 1969; 132:232-44.
14. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
15. Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential designs. Journal of Biopharmaceutical Statistics 2008; 18:1184-1196.
16. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical Recipes. Cambridge University Press: New York, 1986.
17. Hwang IK, Shih WJ, DeCani JS. Group sequential designs using a family of type I error probability spending functions. Statistics in Medicine 1990; 9(12):1439-1445.